BEMO:2000165 · BEMO metric v1.0.0
Study Heterogeneity
A canonical biomedical evidence metric quantifying the scientific credibility, reliability, relevance, or interpretability of study heterogeneity.
- Scientific pillar
- Evidence Synthesis and Certainty
- Source category
- Evidence Certainty and Synthesis
- Output scale
- ContextDependentMixedScale
- Source maturity
- Established
Scientific meaning
What it measures
Assesses study heterogeneity using evidence appropriate to evidence certainty and synthesis, distinguishing random uncertainty from systematic error.
Why it matters
Material weakness in study heterogeneity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.
Measurement criteria
Prespecified operational definition; appropriate comparator or reference; quantified uncertainty; independent or orthogonal corroboration; sensitivity analyses.
Typical methods of assessment
Forest plots; heterogeneity statistics; tau-squared; prediction intervals; funnel plots; regression or selection models; sensitivity analyses.
Computation profile
- Computation mode
- ContextSpecificMetricComputation
- Readiness
- OperationalDefinitionRequired
- Formula status
- ContextSpecificProtocolRequired
- Method family
- metric-specific quantitative or qualitative assessment
- Output datatype
- xsd:anySimpleType
- Unit or scale
- Metric-specific continuous, categorical, or ordinal scale
- Numeric range
- Context dependent
- Directionality
- ContextDependentDirection
Required inputs
- evidence_records
- assessment_context
- operational_definition
- computation_protocol_version
Optional inputs
- weights
- thresholds
- reference_standard
- expert_adjudication
Machine-readable expression
{
"language": "BEMO-Expression-JSON",
"operator": "external_protocol",
"protocolRef": "REQUIRED"
}Computation policies
- Aggregation
- Not specified in source; must be defined and versioned before composite use.
- Normalization
- None by default; any normalization must be justified, versioned, and validated.
- Missing data
- Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material.
- Uncertainty required
- Yes
- Uncertainty method
- Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable.
- Confidence interval required
- Yes
- Threshold policy
- Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction.
- Decision thresholds
- No universal threshold declared
- Quality control
- Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable.
- Calibration
- As applicable; mandatory for probabilistic or normalized outputs.
Applicability and validation
- Evidence object
- Body of evidence / synthesis / outcome
- Evidence level
- Body of evidence / synthesis / outcome
- Study types
- Systematic reviews, meta-analyses, evidence profiles, guidelines
- Domain
- Evidence Certainty and Synthesis
- Required data sources
- Context-specific; use source references, registered studies, primary data, and authoritative biomedical resources as applicable.
- Validation status
- Source maturity: Established; BEMO computation profile requires independent validation.
- Benchmark
- A representative, versioned benchmark set is required before production use.
- Reference standard
- Use an independent reference standard when one exists; document expert-adjudicated alternatives.
- External validation required
- Yes
Interpretation safeguards
Common misinterpretations
Treating study heterogeneity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.
Limitations
Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.
Dependency status
Not yet curated. Closely related metrics are represented; causal or computational dependencies require expert curation.
Source provenance
- Source workbook
- Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx
- Source worksheet
- Biomedical Evidence Metrics
- Source row
- 172
- Source record SHA-256
93fce0e52f596e9f5e6b6636a82da697803846e686e6144faa894115a270196a- Definition source
- Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 172; see source_references
- Ontology IRI
- https://w3id.org/bemo/BEMO_2000165
- Profile IRI
- https://w3id.org/bemo/profile/BEMO_2000165
Scientific references (4)
- https://www.gradeworkinggroup.org/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
- https://www.prisma-statement.org/prisma-2020-checklistSource framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
- https://www.bmj.com/content/358/bmj.j4008Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
- https://www.riskofbias.info/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
Governance and FAIR status
- Lifecycle
- Candidate
- Approval
- Draft
- Owner
- BEMO Project
- Curator
- Unassigned
- Reviewer
- Unassigned
- License
- Pending owner approval; CC BY 4.0 recommended for OBO compatibility.
- Findable
- Provisional: stable local ID assigned; public namespace registration pending.
- Accessible
- Provisional: package is distributable; permanent public release location pending.
- Interoperable
- Yes: OWL 2, RDF, SKOS, SHACL, JSON-LD, CSV, and OBO-style identifiers.
- Reusable
- Provisional: rich metadata supplied; open-license owner approval pending.
- Governance note
- Candidate term pending scientific, ontology-engineering, and computation-method review.
- Editor note
- Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use.